Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony T Reder

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|March 8, 2018
Effective treatment of CLIPPERS with long-term use of rituximabVeronica P Cipriani, Nancy Arndt, Peter Pytel, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Short-term and long-term safety and tolerability of interferon β-1b in multiple sclerosisAnthony T Reder, Joel F Oger, Ludwig Kappos, et al.
Sleep Medicine|August 30, 2020
The rhythms of AMBEs (arousal-related motor behavioral episodes) in Agrypnia Excitata: a video motor analysisArturo Garay, Daniela L Giardino, Cristián Huck-Iriart, et al.
Frontiers in Neurology|May 11, 2023
Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: Gene expression and protein profilesChloe C Fong, Julian Spencer, Quentin Howlett-Prieto, et al.
Frontiers in Neurology|August 24, 2023
Corrigendum: Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: gene expression and protein profilesChloe C Fong, Julian Spencer, Quentin Howlett-Prieto, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Severe early bilateral macular edema following fingolimod therapyOscar Jim Michael Coppes, Ismael Gutierrez, Anthony T Reder, et al.
Journal of the Neurological Sciences|July 19, 2017
Early MRI results and odds of attaining 'no evidence of disease activity' status in MS patients treated with interferon β-1a in the EVIDENCE studyPatricia K Coyle, Anthony T Reder, Mark S Freedman, et al.
Expert Review of Neurotherapeutics|December 17, 2010
Fingolimod for the treatment of relapsing multiple sclerosisDouglas R Jeffery, Clyde E Markowitz, Anthony T Reder, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 5, 2019
Vitamin D enhances responses to interferon-β in MSXuan Feng, Zhe Wang, Quentin Howlett-Prieto, et al.
Plos One|September 19, 2025
IFN-β therapy rescues dysregulated IFN-stimulated proteins, serum cytokines, and neurotrophic factors in multiple sclerosis: Multiplex analysis of short-term and long-term IFN responsesLei Li, Maya Olcer, Zhe Wang, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Neurology(R) Neuroimmunology & Neuroinflammation|March 8, 2018
Effective treatment of CLIPPERS with long-term use of rituximabVeronica P Cipriani, Nancy Arndt, Peter Pytel, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Short-term and long-term safety and tolerability of interferon β-1b in multiple sclerosisAnthony T Reder, Joel F Oger, Ludwig Kappos, et al.
Sleep Medicine|August 30, 2020
The rhythms of AMBEs (arousal-related motor behavioral episodes) in Agrypnia Excitata: a video motor analysisArturo Garay, Daniela L Giardino, Cristián Huck-Iriart, et al.
Frontiers in Neurology|May 11, 2023
Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: Gene expression and protein profilesChloe C Fong, Julian Spencer, Quentin Howlett-Prieto, et al.
Frontiers in Neurology|August 24, 2023
Corrigendum: Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: gene expression and protein profilesChloe C Fong, Julian Spencer, Quentin Howlett-Prieto, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Severe early bilateral macular edema following fingolimod therapyOscar Jim Michael Coppes, Ismael Gutierrez, Anthony T Reder, et al.
Journal of the Neurological Sciences|July 19, 2017
Early MRI results and odds of attaining 'no evidence of disease activity' status in MS patients treated with interferon β-1a in the EVIDENCE studyPatricia K Coyle, Anthony T Reder, Mark S Freedman, et al.
Expert Review of Neurotherapeutics|December 17, 2010
Fingolimod for the treatment of relapsing multiple sclerosisDouglas R Jeffery, Clyde E Markowitz, Anthony T Reder, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 5, 2019
Vitamin D enhances responses to interferon-β in MSXuan Feng, Zhe Wang, Quentin Howlett-Prieto, et al.
Plos One|September 19, 2025
IFN-β therapy rescues dysregulated IFN-stimulated proteins, serum cytokines, and neurotrophic factors in multiple sclerosis: Multiplex analysis of short-term and long-term IFN responsesLei Li, Maya Olcer, Zhe Wang, et al.
Pageof 9